Chief Medical Officer · Lyell Immunopharma, Inc. · Common Stock
Side
SELL
Value
$3,642
Shares
422
Price
$8.63
Executed
Oct 12, 2026
Disclosed
Oct 13, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 12 executedOct 13, 2026 disclosed
LYEL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Aguirre Jarrad Mattieu filed this Form 4 reporting a open-market sale of LYEL on Oct 12, 2026. It became public on Oct 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Aguirre Jarrad Mattieucik:0002150331
Issuer
Lyell Immunopharma, Inc.cik:0001806952
Revision history · 0
No field has changed since this record was first ingested.
